Literature DB >> 5417847

Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation.

G Härtel, A Louhija, A Konttinen, P I Halonen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5417847      PMCID： PMC487272          DOI： 10.1136/hrt.32.1.57

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  8 in total

1.  QUANTITATIVE DETERMINATION OF QUINIDINE IN PLASMA.

Authors:  G CRAMER; B ISAKSSON
Journal:  Scand J Clin Lab Invest       Date:  1963       Impact factor: 1.713

2.  FURTHER EXPERIENCE OF ELECTRICAL CONVERSION OF ATRIAL FIBRILLATION TO SINUS RHYTHM: ANALYSIS OF 100 PATIENTS.

Authors:  S ORAM; J P DAVIES
Journal:  Lancet       Date:  1964-06-13       Impact factor: 79.321

3.  MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION.

Authors:  J W HURST; E A PAULK; H D PROCTOR; R C SCHLANT
Journal:  Am J Med       Date:  1964-11       Impact factor: 4.965

4.  QUINIDINE-INDUCED SYNCOPE.

Authors:  P DAVIES; D LEAK; S ORAM
Journal:  Br Med J       Date:  1965-08-28

5.  "Cardioversion" of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients.

Authors:  B LOWN; M G PERLROTH; S KAIDBEY; T ABE; D E HARKEN
Journal:  N Engl J Med       Date:  1963-08-15       Impact factor: 91.245

6.  Factors affecting cardioversion of atrial arrhythmias with special reference to quinidine.

Authors:  J I Hall; D R Wood
Journal:  Br Heart J       Date:  1968-01

7.  Direct current conversion of atrial fibrillation.

Authors:  P B Halmos
Journal:  Br Heart J       Date:  1966-05

8.  The use of quinidine in cardioversion.

Authors:  M Rossi; B Lown
Journal:  Am J Cardiol       Date:  1967-02       Impact factor: 2.778
  8 in total
  10 in total

1.  Comparison of quinidine plasma concentration curves following oral administration of some short- and long-acting formulations.

Authors:  G M Frigo; E Perucca; M Teggia-Droghi; G Gatti; A Mussini; J Salerno
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

2.  [Drug therapy of tachyarrhythmias (author's transl)].

Authors:  K Theisen
Journal:  Klin Wochenschr       Date:  1978-02-15

3.  Quinidine before direct current countershock. A controlled study.

Authors:  L Hillestad; J Dale; O Storstein
Journal:  Br Heart J       Date:  1972-02

4.  Electroconversion of atrial fibrillation after mitral valvotomy.

Authors:  A R Upton; M Honey
Journal:  Br Heart J       Date:  1971-09

5.  Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation. A controlled clinical study.

Authors:  L Hillestad; C Bjerkelund; J Dale; J Maltau; O Storstein
Journal:  Br Heart J       Date:  1971-07

6.  Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm.

Authors:  T Södermark; B Jonsson; A Olsson; L Orö; H Wallin; O Edhag; A Sjögren; M Danielsson; G Rosenhamer
Journal:  Br Heart J       Date:  1975-05

7.  Absorption of quinidine from an enteric-coated preparation.

Authors:  D Fremstad; O G Nilsen; J Amlie; L Storstein; B Olsson; S Jacobsen
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

8.  Quinidine for pharmacological cardioversion of atrial fibrillation: a retrospective analysis in 501 consecutive patients.

Authors:  Bernhard Schwaab; Alexander Katalinic; Uta Maria Böge; Jürgen Loh; Peter Blank; Tatjana Kölzow; Dirk Poppe; Hendrik Bonnemeier
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-04       Impact factor: 1.468

Review 9.  The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations.

Authors:  S Nattel; T Hadjis; M Talajic
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

10.  Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Authors:  Lucie Valembois; Etienne Audureau; Andrea Takeda; Witold Jarzebowski; Joël Belmin; Carmelo Lafuente-Lafuente
Journal:  Cochrane Database Syst Rev       Date:  2019-09-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.